CLINICAL_TRIALS
withdrawal
· 2019-04-18
Clinical Trial Update: Pilot E2 for Hypogonadal Women With CFBD [Phase 4]
Summary
A Phase 4 pilot trial (E2) for hypogonadal women with cystic fibrosis-related bone disease was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Emory University | Conditions: Cystic Fibrosis Related Bone Disease | Phase 4 | Status: WITHDRAWN